Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.
about
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety and efficacy of lenalid ...... e Fondazione Italiana Linfomi.
@en
Safety and efficacy of lenalid ...... e Fondazione Italiana Linfomi.
@nl
type
label
Safety and efficacy of lenalid ...... e Fondazione Italiana Linfomi.
@en
Safety and efficacy of lenalid ...... e Fondazione Italiana Linfomi.
@nl
prefLabel
Safety and efficacy of lenalid ...... e Fondazione Italiana Linfomi.
@en
Safety and efficacy of lenalid ...... e Fondazione Italiana Linfomi.
@nl
P2093
P2860
P50
P1433
P1476
Safety and efficacy of lenalid ...... e Fondazione Italiana Linfomi.
@en
P2093
Angela Ferrari
Angelo Michele Carella
Anna Lia Molinari
Annalisa Chiapella
Armando Santoro
Daniele Vallisa
Francesco Di Raimondo
Franco Silvestris
Luciano Guardigni
Luigi Marcheselli
P2860
P304
P356
10.3324/HAEMATOL.2015.139329
P50
P577
2016-02-08T00:00:00Z